Prognostic stratification in early-stage hepatocellular carcinoma: Imaging biomarkers are needed
- PMID: 38517296
- DOI: 10.1111/liv.15869
Prognostic stratification in early-stage hepatocellular carcinoma: Imaging biomarkers are needed
Comment on
-
A Transformer-Based microvascular invasion classifier enhances prognostic stratification in HCC following radiofrequency ablation.Liver Int. 2024 Apr;44(4):894-906. doi: 10.1111/liv.15846. Epub 2024 Jan 23. Liver Int. 2024. PMID: 38263714
References
REFERENCES
-
- Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J Hepatol. 2022;76(3):681‐693.
-
- Takayama T, Hasegawa K, Izumi N, et al. Surgery versus radiofrequency ablation for small hepatocellular carcinoma: a randomized controlled trial (SURF trial). Liver Cancer. 2022;11(3):209‐218.
-
- Mohkam K, Dumont PN, Manichon AF, et al. No‐touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm. J Hepatol. 2018;68(6):1172‐1180.
-
- Wang W, Wang Y, Song D, et al. A transformer‐based microvascular invasion classifier enhances prognostic stratification in HCC following radiofrequency ablation. Liver Int. 2024. doi:10.1111/liv.15846
-
- Doyle A, Gorgen A, Muaddi H, et al. Outcomes of radiofrequency ablation as first‐line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients. J Hepatol. 2019;70(5):866‐873.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical